BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15490153)

  • 1. MICA response to gliadin in intestinal mucosa from celiac patients.
    Martín-Pagola A; Pérez-Nanclares G; Ortiz L; Vitoria JC; Hualde I; Zaballa R; Preciado E; Castaño L; Bilbao JR
    Immunogenetics; 2004 Nov; 56(8):549-54. PubMed ID: 15490153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease.
    Hüe S; Mention JJ; Monteiro RC; Zhang S; Cellier C; Schmitz J; Verkarre V; Fodil N; Bahram S; Cerf-Bensussan N; Caillat-Zucman S
    Immunity; 2004 Sep; 21(3):367-77. PubMed ID: 15357948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the expression of MICA in small intestinal mucosa of patients with celiac disease.
    Martín-Pagola A; Ortiz L; Pérez de Nanclares G; Vitoria JC; Castaño L; Bilbao JR
    J Clin Immunol; 2003 Nov; 23(6):498-503. PubMed ID: 15031637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptive and innate immune responses in celiac disease.
    Gianfrani C; Auricchio S; Troncone R
    Immunol Lett; 2005 Jul; 99(2):141-5. PubMed ID: 15876458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gliadin does not induce mucosal inflammation or basophil activation in patients with nonceliac gluten sensitivity.
    Bucci C; Zingone F; Russo I; Morra I; Tortora R; Pogna N; Scalia G; Iovino P; Ciacci C
    Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1294-1299.e1. PubMed ID: 23639603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-15 interferes with suppressive activity of intestinal regulatory T cells expanded in Celiac disease.
    Zanzi D; Stefanile R; Santagata S; Iaffaldano L; Iaquinto G; Giardullo N; Lania G; Vigliano I; Vera AR; Ferrara K; Auricchio S; Troncone R; Mazzarella G
    Am J Gastroenterol; 2011 Jul; 106(7):1308-17. PubMed ID: 21468011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gliadin-mediated proliferation and innate immune activation in celiac disease are due to alterations in vesicular trafficking.
    Barone MV; Zanzi D; Maglio M; Nanayakkara M; Santagata S; Lania G; Miele E; Ribecco MT; Maurano F; Auricchio R; Gianfrani C; Ferrini S; Troncone R; Auricchio S
    PLoS One; 2011 Feb; 6(2):e17039. PubMed ID: 21364874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gliadin peptides as triggers of the proliferative and stress/innate immune response of the celiac small intestinal mucosa.
    Barone MV; Troncone R; Auricchio S
    Int J Mol Sci; 2014 Nov; 15(11):20518-37. PubMed ID: 25387079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential mucosal IL-17 expression in two gliadin-induced disorders: gluten sensitivity and the autoimmune enteropathy celiac disease.
    Sapone A; Lammers KM; Mazzarella G; Mikhailenko I; Cartenì M; Casolaro V; Fasano A
    Int Arch Allergy Immunol; 2010; 152(1):75-80. PubMed ID: 19940509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term and acute effects of gliadin on small intestine of patients on potentially pathogenic networks in celiac disease.
    Castellanos-Rubio A; Santin I; Martin-Pagola A; Irastorza I; Castaño L; Vitoria JC; Bilbao JR
    Autoimmunity; 2010 Mar; 43(2):131-9. PubMed ID: 19814655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4+NKG2D+ T cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactions.
    Allez M; Tieng V; Nakazawa A; Treton X; Pacault V; Dulphy N; Caillat-Zucman S; Paul P; Gornet JM; Douay C; Ravet S; Tamouza R; Charron D; Lémann M; Mayer L; Toubert A
    Gastroenterology; 2007 Jun; 132(7):2346-58. PubMed ID: 17570210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gliadin, zonulin and gut permeability: Effects on celiac and non-celiac intestinal mucosa and intestinal cell lines.
    Drago S; El Asmar R; Di Pierro M; Grazia Clemente M; Tripathi A; Sapone A; Thakar M; Iacono G; Carroccio A; D'Agate C; Not T; Zampini L; Catassi C; Fasano A
    Scand J Gastroenterol; 2006 Apr; 41(4):408-19. PubMed ID: 16635908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The copolymer P(HEMA-co-SS) binds gluten and reduces immune response in gluten-sensitized mice and human tissues.
    Pinier M; Fuhrmann G; Galipeau HJ; Rivard N; Murray JA; David CS; Drasarova H; Tuckova L; Leroux JC; Verdu EF
    Gastroenterology; 2012 Feb; 142(2):316-25.e1-12. PubMed ID: 22079593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The gliadin-CFTR connection: new perspectives for the treatment of celiac disease.
    Maiuri L; Villella VR; Raia V; Kroemer G
    Ital J Pediatr; 2019 Mar; 45(1):40. PubMed ID: 30898172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local challenge on oral mucosa with an alpha-gliadin related synthetic peptide in patients with celiac disease.
    Lähteenoja H; Mäki M; Viander M; Räihä I; Vilja P; Rantala I; Toivanen A; Syrjänen S
    Am J Gastroenterol; 2000 Oct; 95(10):2880-7. PubMed ID: 11051363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gliadin induced changes in the expression of MHC-class II antigens by human small intestinal epithelium. Organ culture studies with coeliac disease mucosa.
    Fais S; Maiuri L; Pallone F; De Vincenzi M; De Ritis G; Troncone R; Auricchio S
    Gut; 1992 Apr; 33(4):472-5. PubMed ID: 1582589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P31-43, an undigested gliadin peptide, mimics and enhances the innate immune response to viruses and interferes with endocytic trafficking: a role in celiac disease.
    Nanayakkara M; Lania G; Maglio M; Auricchio R; De Musis C; Discepolo V; Miele E; Jabri B; Troncone R; Auricchio S; Barone MV
    Sci Rep; 2018 Jul; 8(1):10821. PubMed ID: 30018339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural insights on P31-43, a gliadin peptide able to promote an innate but not an adaptive response in celiac disease.
    Calvanese L; Nanayakkara M; Aitoro R; Sanseverino M; Tornesello AL; Falcigno L; D'Auria G; Barone MV
    J Pept Sci; 2019 May; 25(5):e3161. PubMed ID: 30912242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of intestinal mucosal toxicity of Triticum monococcum in celiac disease patients.
    Pizzuti D; Buda A; D'Odorico A; D'Incà R; Chiarelli S; Curioni A; Martines D
    Scand J Gastroenterol; 2006 Nov; 41(11):1305-11. PubMed ID: 17060124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro model of the pathogenesis of celiac disease.
    Oberhuber G; Schwarzenhofer M; Vogelsang H
    Dig Dis; 1998; 16(6):341-4. PubMed ID: 10207219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.